Authors, years | Participants | Intervention | Intervention providers | Outcome measures | Duration | Conclusion |
---|---|---|---|---|---|---|
Mattei da Silva, ÂT et al. 2020 [7], Brazil | 94 patients with hypertension Experiment group: 1) Age: 49.4 ± 6.4 2) Size: 47 Control group: 1) Age: 49.2 ± 8.4 2) Size: 47 | Case management: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning | Nurses | •SBP*, DBP* •BMI* | 12 months | The intervention group’s SBP*, DBP* and BMI* decreased significantly compared to those of the control group |
Kastarinen MJ et al. 2002 [36], Finland | 587 patients with hypertension Experiment-group: 1) Age: 54.4 ± 10.1 2) Size: 304 Control-group: 1) Age: 54.2 ± 9.9 2) Size: 283 | Disease-specific: Evidence-based guidelines and information; Regular follow up; Patients participate in effective programs | Physician and a nutritionist; Local public health nurses | •SBP*, DBP* •BMI* | 12 months | Significant reductions after 1 year both in SBP* and in DBP* were in favour of the intervention group. |
Aubert RE et al. 2017 [30], America | 138 patients with diabetes Experiment-group: 1) Age: 53 (Interquartile range: 47–61) 2) Size: 71 Control-group: 1) Age: 54 (Interquartile range: 46–60) 2) Size: 67 | Case management: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | a board-certified family medicine physician and an endocrinologist; Local public health nurses | •HbA1c* | 12 months | A significant decrease in HbA1c* in intervention group. |
Hurwitz B et al. 1993 [35], British | 181 patients with diabetes Experiment-group: 1) Age: 62.0 ± 11.2 2) Size: 89 Control-group: 1) Age: 63.1 ± 8.6 2) Size: 92 | Patient-centred medical home: Evidence-based guidelines and information; Regular follow up; Timely reminder | General practitioners; Clinic doctors | •HbA1c* | 6 months | Decrease in HbA1c* in intervention group. |
Gao JL et al. 2015 [6], China | 1204 patients with hypertension Experiment-group: 1) Age: 66.0 ± 9.3 2) Size: 600 Control-group: 1) Age: 67.1 ± 10.3 2) Size: 604 | Patient-centred medical home: Evidence-based guidelines and information; Regular follow up; Individual care planning; Patients participate in effective programs | General practitioners | •SBP*, DBP* •BMI* | 12 months | The average DBP* decrease in the intervention group was significantly greater than that in the control group. |
Hacihasanoğlu R et al. 2010 [5], Turkey | 80 patients with hypertension Experiment-group: 1) Age: 56.92 ± 8.04 2) Size: 40 Control-group: 1) Age: 55.62 ± 8.46 2) Size: 40 | Patient-centred medical home: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | Nurses | •SBP*, DBP* •BMI* | 12 months | A significant decrease in BP* in intervention group. |
Li YD et al. 2003 [40], China | 415 patients with diabetes Experiment-group: 1) Age: 66.77 ± 7.29 2) Size: 215 Control-group: 1) Age: 67.95 ± 7.61 2) Size: 200 | Disease-specific: Evidence-based guidelines and information; Regular follow up; Timely reminder; Patients participate in effective programs; Group visit | staff in general hospital; staff in community hospital | •HbA1c* | 12 months | A significant decrease in BP* and HbA1c* in the intervention group. |
Huang HL et al. 2019 [34], China | 222 patients with diabetes Experiment-group: 1) Age: 68.3 ± 5.1 2) Size: 110 Control-group: 1) Age: 68.2 ± 5.4 2) Size: 112 | Disease-specific: Evidence-based guidelines and information; Regular follow up; Individual care planning; Patients participate in effective programs | specialist physician general practitioner | •HbA1c* | 6 months 12 months | A significant decrease in BP* in the intervention group after 3, 6, and 12 months. A significant decrease in HbA1c* in intervention group after 6 months. |
Han Y et al. 2019 [41], China | 100 patients with diabetes Experiment-group: 50 Control-group: 50 Age: 25 ~ 75 | Disease-specific: Evidence-based guidelines and information; Regular follow up; Individual care planning | staff in general hospital; staff in community hospital | •HbA1c* | 6 months 12 months | A significant decrease in HbA1c* in the intervention group after 12 months. |
Gary TL et al. 2009 [33], America | 488 patients with diabetes Experiment-group: 1) Age: 59 ± 11 2) Size: 235 Control-group: 1) Age: 56 ± 11 2) Size: 253 | Case management: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | Nurses; Community health worker | •HbA1c* | 24 months | Those who had more visits with professional workers in intervention group had a statistically significant decline in HbA1c* level compared with the control group. |
Glasgow RE et al. 2005 [39], America | 733 patients with diabetes Experiment-group: 1) Age: 62 ± 1.4 2) Size: 379 Control-group: 1) Age: 64 ± 1.3 2) Size: 354 | Disease-specific: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | Primary care physician; care manager | •HbA1c* | 12 months | Both conditions improved on measures of HbA1c*, but there was not a significant difference between conditions. |
Piatt GA et al. 2006 [4], America | 73 patients with diabetes Experiment-group: 1) Age: 69.7 ± 10.7 2) Size: 27 Control-group: 1) Age: 68.6 ± 8.6 2) Size: 46 | Chronic Care Model: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | Physician; Nurses practitioners/physician assistants Behaviourist | •HbA1c* | 12 months | A marked decline in HbA1c* was observed in the intervention group but not in the control group. |
Kong JXx et al. 2018 [37], China | 258 patients with diabetes Experiment-group: 1) Age: 69.12 ± 10.54 2) Size: 134 Control-group: 1) Age: 71.48 ± 8.79 2) Size: 124 | Chronic Care Model: Evidence-based guidelines and information; Timely reminder; Regular follow up; Individual care planning; Patients participate in effective programs | Physicians | •HbA1c* | 9 months | The intervention group had a remarkable reduction in HbA1c*. |
Cicolini G et al. 2014 [32] Italy | 298 patients with hypertension Experiment-group: 1) Age: 59.8 ± 15.0 2) Size: 100 Control-group: 1) Age: 58.3 ± 13.9 2) Size: 98 | Disease-specific: Evidence-based guidelines and information; Regular follow up; Patients participate in effective programs | Nurses | •SBP*, DBP* •BMI* | 6 months | The intervention group showed a significantly greater improvement in BMI* and SBP* and DBP*. |
Beune EJ et al. 2014 [31], Netherlands | 139 patients with hypertension Experiment-group: 1) Age: 53.3 ± 10.2 2) Size: 71 Control-group: 1) Age: 54.6 ± 9.5 2) Size: 68 | Disease-specific: Individual care planning; Regular follow up; Patients participate in effective programs | Nurses | •SBP*, DBP* •BMI* | 6 months | In contrast to SBP* and BMI*, effect of the intervention on the between-group difference in DBP* reduction was significant. |
Leiva A et al. 2014 [38], Spain | 208 patients with hypertension Experiment-group: 1) Age: 64.5 ± 9.8 2) Size: 103 Control-group: 1) Age: 66.7 ± 11.7 2) Size: 105 | Disease-specific: Evidence-based guidelines and information; Timely reminder; Regular follow up; Family support; Patients participate in effective programs | Nurse | •SBP*, DBP* | 12 months | The SBP* in the intervention group was 151.3 versus 153.7 in the control group (P = 0.294). The DBP* did not differ between groups (83.4 versus 83.6). |